[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, cabozantinib has been shown to be effective in the treatment of hepatocellular carcinoma (HCC) in multiple clinical trials. The phase 3 CELESTIAL trial demonstrated that cabozantinib improved overall survival and progression-free survival in patients with advanced HCC who had previously received sorafenib. Other studies and reviews also support the efficacy of cabozantinib in HCC. Therefore, the answer is A. yes, cabozantinib is effective for Hepatocellular Carcinoma.\", \"answer_choice\": \"A\"}"
]